Clinical Trial Update: G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the hemolysis risk of tafenoquine (TFQ) in relation to G6PD status. The trial has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Tafenoquine (tafenoquine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria | Phase 1 | Status: COMPLETED